{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:34:21Z","timestamp":1769301261613,"version":"3.49.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1093\/humrep\/deh789","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T01:13:21Z","timestamp":1109380401000},"page":"1562-1568","source":"Crossref","is-referenced-by-count":49,"title":["Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome"],"prefix":"10.1093","volume":"20","author":[{"given":"E. Vrta\u010dnik","family":"Bokal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Meden","family":"Vrtovec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Virant","family":"Klun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Verdenik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,6]]},"reference":[{"key":"key\n\t\t\t\t20171010140911_R1","doi-asserted-by":"crossref","unstructured":"Aboulghar MA, Mansour RT, Serour GI, Maguid Ramzy A and Amin YM (1997) Oocyte quality in patients with severe ovarian hyperstimulation syndrome. Fertil Steril68, 1017\u20131021.","DOI":"10.1016\/S0015-0282(97)00409-3"},{"key":"key\n\t\t\t\t20171010140911_R2","doi-asserted-by":"crossref","unstructured":"Acosta TJ, Ozawa T, Kobayashi S, Hayashi K, Ohtani M, Kraetzl WD, Sato K, Schams D and Miyamoto A (2000) Periovulatory changes in the local release of vasoactive peptides, prostaglandin f(2alpha), and steroid hormones from bovine mature follicles in vivo. Biol Reprod63, 1253\u20131261.","DOI":"10.1095\/biolreprod63.5.1253"},{"key":"key\n\t\t\t\t20171010140911_R3","doi-asserted-by":"crossref","unstructured":"Acosta TJ, Hayashi KG, Ohtani M and Miyamoto A (2003) Local changes in blood flow within the preovulatory follicle wall and early corpus luteum in cows. Reproduction125, 759\u2013767.","DOI":"10.1530\/rep.0.1250759"},{"key":"key\n\t\t\t\t20171010140911_R4","doi-asserted-by":"crossref","unstructured":"Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J and Jacobs HS (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet2, 1375\u20131379.","DOI":"10.1016\/S0140-6736(85)92552-8"},{"key":"key\n\t\t\t\t20171010140911_R5","doi-asserted-by":"crossref","unstructured":"Agrawal R, Conway G, Sladkevicius P, Tan SL, Engmann L, Payne N, Bekir J, Campbell S and Jacobs H (1998) Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril70, 651\u2013658.","DOI":"10.1016\/S0015-0282(98)00249-0"},{"key":"key\n\t\t\t\t20171010140911_R6","doi-asserted-by":"crossref","unstructured":"Agrawal R, Jacobs H, Payne N and Conway G (2002) Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril78, 1164\u20131169.","DOI":"10.1016\/S0015-0282(02)04242-5"},{"key":"key\n\t\t\t\t20171010140911_R7","doi-asserted-by":"crossref","unstructured":"Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogio G and Genazzani AR (1998) Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation in women enrolled in an in vitro fertilization program. Fertil Steril70, 560\u2013564.","DOI":"10.1016\/S0015-0282(98)00221-0"},{"key":"key\n\t\t\t\t20171010140911_R8","doi-asserted-by":"crossref","unstructured":"Balakier H, Sojecki A, Motamedi G and Librach C (2004) Time-dependent capability of human oocytes for activation and pronuclear formation during metaphase II arrest. Hum Reprod19, 982\u2013987.","DOI":"10.1093\/humrep\/deh158"},{"key":"key\n\t\t\t\t20171010140911_R9","doi-asserted-by":"crossref","unstructured":"Bhal PS, Pugh ND, Chui DK, Gregory L, Walker SM and Shaw RW (1999) The use of transvaginal power Doppler ultrasonography to evaluate the relationship between perifollicular vascularity and outcome in in-vitro fertilization treatment cycles. Hum Reprod14, 939\u2013945.","DOI":"10.1093\/humrep\/14.4.939"},{"key":"key\n\t\t\t\t20171010140911_R10","doi-asserted-by":"crossref","unstructured":"Chian RC (2004) In-vitro maturation of immature oocytes for infertile women with PCOS. Reprod Biomed Online8, 547\u2013552.","DOI":"10.1016\/S1472-6483(10)61101-7"},{"key":"key\n\t\t\t\t20171010140911_R11","unstructured":"Cresswell JL, Barker DJ and Osmond C (1997) Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet350, 1131\u20131135."},{"key":"key\n\t\t\t\t20171010140911_R12","doi-asserted-by":"crossref","unstructured":"Culler MD, Tarlatzis BC, Lightman A and Fernandez LA (1986) Angiotensin II like immunoreactivity in human ovarian follicular fluid. J Clin Endocrinol Metab62, 613\u2013615.","DOI":"10.1210\/jcem-62-3-613"},{"key":"key\n\t\t\t\t20171010140911_R13","unstructured":"Daud AI, Bumpus FM and Husain A (1990) Characterization of angiotensin I-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation. Endocrinology126, 2927\u20132935."},{"key":"key\n\t\t\t\t20171010140911_R14","unstructured":"Einspanier R, Muller K, Bieser B, Kosmann M and Schams D (1999) Differential expression of VEGF applied during in vitro maturation of oocytes. J Reprod Fertil Abstr Ser23, 7."},{"key":"key\n\t\t\t\t20171010140911_R15","doi-asserted-by":"crossref","unstructured":"Ferrara N (2000) VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol11, 617\u2013624.","DOI":"10.1016\/S0958-1669(00)00153-1"},{"key":"key\n\t\t\t\t20171010140911_R16","doi-asserted-by":"crossref","unstructured":"Franks S (1989) Polycystic ovary syndrome: a changing perspective. Clin Endocrinol31, 87\u2013120.","DOI":"10.1111\/j.1365-2265.1989.tb00457.x"},{"key":"key\n\t\t\t\t20171010140911_R17","doi-asserted-by":"crossref","unstructured":"Glorioso N, Atlas SA, Laragh JH, Jewelewicz R and Sealey JE (1986) Prorenin in high concentrations in human ovarian follicular fluid. Science233, 1422\u20131424.","DOI":"10.1126\/science.3529392"},{"key":"key\n\t\t\t\t20171010140911_R18","unstructured":"Hagemann A (1997) Solution of methodological problems in prorenin measurement and investigations of tissue renin-angiotensin systems in the female reproductive tract. Dan Med Bull44, 486\u2013498."},{"key":"key\n\t\t\t\t20171010140911_R19","doi-asserted-by":"crossref","unstructured":"Homburg R (2002) What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Hum Reprod17, 2495\u20132499.","DOI":"10.1093\/humrep\/17.10.2495"},{"key":"key\n\t\t\t\t20171010140911_R20","doi-asserted-by":"crossref","unstructured":"Homburg R, Berkowitz D, Levy T, Felderberg D, Ashkenazi J and Ben-Rafael Z (1993) In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril60, 858\u2013863.","DOI":"10.1016\/S0015-0282(16)56287-6"},{"key":"key\n\t\t\t\t20171010140911_R21","doi-asserted-by":"crossref","unstructured":"Huang FJ, Huang HW, Lan KC, Kung FT, Lin YC, Chang HW and Chang SY (2002) The maturity of human cumulus-free oocytes is positively related to blastocyst development and viability. J Assist Reprod Genet19, 555\u2013560.","DOI":"10.1023\/A:1021259031267"},{"key":"key\n\t\t\t\t20171010140911_R22","doi-asserted-by":"crossref","unstructured":"Huang FJ, Lan KC, Kung FT, Tsai MY, Chang CY, Huang HW, Lin YC and Chang SY (2004) Human cumulus-free oocyte maturational profile and in vitro developmental potential after stimulation with recombinant versus urinary FSH. Hum Reprod19, 306\u2013315.","DOI":"10.1093\/humrep\/deh062"},{"key":"key\n\t\t\t\t20171010140911_R23","doi-asserted-by":"crossref","unstructured":"Itskovitz J, Rubattu S, Rosenwaks Z, Liu HC and Sealey JE (1991) Relationship of follicular fluid prorenin to oocyte maturation, steroid levels, and outcome of in vitro fertilization. J Clin Endocrinol Metab72, 165\u2013171.","DOI":"10.1210\/jcem-72-1-165"},{"key":"key\n\t\t\t\t20171010140911_R24","doi-asserted-by":"crossref","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR and Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab83, 3078\u20133082.","DOI":"10.1210\/jc.83.9.3078"},{"key":"key\n\t\t\t\t20171010140911_R25","doi-asserted-by":"crossref","unstructured":"Kuo TC, Endo K, Dharmarajan AM, Miyazaki T, Atlas SJ and Wallach EE (1991) Direct effect of angiotensin II on the in-vitro perfused rabbit ovary. J Reprod Fertil92, 469\u2013474.","DOI":"10.1530\/jrf.0.0920469"},{"key":"key\n\t\t\t\t20171010140911_R26","doi-asserted-by":"crossref","unstructured":"Lin YC, Chang SY, Lan KC, Huang HW, Chang CY, Tsai MY, Kung FT and Huang FJ (2003) Human oocyte maturity in vivo determines the outcome of blastocyst development in vitro. J Assist Reprod Genet20, 506\u2013512.","DOI":"10.1023\/B:JARG.0000013651.37866.0c"},{"key":"key\n\t\t\t\t20171010140911_R27","doi-asserted-by":"crossref","unstructured":"Loret de Mola JR, Goldfarb JM, Hecht BR, Babbo CJ and Friedlander MA (1999) Gonadotropins induce higher active renin levels in the follicular fluid of normal and hyperstimulated cycles. Gynecol Endocrinol13, 155\u2013160.","DOI":"10.3109\/09513599909167549"},{"key":"key\n\t\t\t\t20171010140911_R28","doi-asserted-by":"crossref","unstructured":"Luo H, Kimura K, Aoki M and Hirako M (2002) Effect of vascular endothelial growth factor on maturation, fertilization and developmental competence of bovine oocytes. J Vet Med Sci64, 803\u2013806.","DOI":"10.1292\/jvms.64.803"},{"key":"key\n\t\t\t\t20171010140911_R29","doi-asserted-by":"crossref","unstructured":"Luo H, Kimura K, Aoki M and Hirako M (2002) Vascular endothelial growth factor (VEGF) promotes the early development of bovine embryo in the presence of cumulus cells. J Vet Med Sci64, 967\u2013971.","DOI":"10.1292\/jvms.64.967"},{"key":"key\n\t\t\t\t20171010140911_R30","doi-asserted-by":"crossref","unstructured":"MacDougall MJ, Tan SL, Balen A and Jacobs HS (1993) A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod8, 233\u2013237.","DOI":"10.1093\/oxfordjournals.humrep.a138029"},{"key":"key\n\t\t\t\t20171010140911_R31","doi-asserted-by":"crossref","unstructured":"Mansour RA, Aboulghar MA and Serour GI (1994) Study of the optimum time for human chorionic gonadotropin \u2013- ovum pickup interval in in vitro fertilization. J Assist Reprod Genet11, 478\u2013481.","DOI":"10.1007\/BF02215712"},{"key":"key\n\t\t\t\t20171010140911_R32","doi-asserted-by":"crossref","unstructured":"Mikkelsen AL and Lindenberg S (2001) Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study. Reproduction122, 587\u2013592.","DOI":"10.1530\/rep.0.1220587"},{"key":"key\n\t\t\t\t20171010140911_R33","doi-asserted-by":"crossref","unstructured":"Palumbo A, Pourmotabbed G, Cacangiu ML, Andrade-Gordon P, Roa L, DeCherney A and Naftolin F (1993) Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertil Steril60, 280\u2013284.","DOI":"10.1016\/S0015-0282(16)56098-1"},{"key":"key\n\t\t\t\t20171010140911_R34","doi-asserted-by":"crossref","unstructured":"Peach MJ (1977) Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev57, 313\u2013370.","DOI":"10.1152\/physrev.1977.57.2.313"},{"key":"key\n\t\t\t\t20171010140911_R35","doi-asserted-by":"crossref","unstructured":"Pellicer A, Palumbo A, DeCherney AH and Naftolin F (1988) Blockage of ovulation by an angiotensin antagonist. Science240, 1660\u20131661.","DOI":"10.1126\/science.3381087"},{"key":"key\n\t\t\t\t20171010140911_R36","doi-asserted-by":"crossref","unstructured":"Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J and Simon C (1999) The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertil Steril71, 482\u2013489.","DOI":"10.1016\/S0015-0282(98)00484-1"},{"key":"key\n\t\t\t\t20171010140911_R37","unstructured":"Richard DE, Berra E and Pouyssegur J (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1 alpha in vascular smooth muscle cells. J Biol Chem275, 26765\u201326771."},{"key":"key\n\t\t\t\t20171010140911_R38","unstructured":"Schenker JG and Weinstein D (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil Steril30, 225\u2013268."},{"key":"key\n\t\t\t\t20171010140911_R39","doi-asserted-by":"crossref","unstructured":"Shoham Z, Jacobs HS and Insler V (1993) Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril59, 1153\u20131161.","DOI":"10.1016\/S0015-0282(16)55968-8"},{"key":"key\n\t\t\t\t20171010140911_R40","doi-asserted-by":"crossref","unstructured":"Simon C, Caballero-Campo P, Garcia-Velasco JA and Pellicer A (1998) Potential implications of chemokines in reproductive function: an attractive idea. J Reprod Immunol38, 169\u2013193.","DOI":"10.1016\/S0165-0378(98)00031-X"},{"key":"key\n\t\t\t\t20171010140911_R41","doi-asserted-by":"crossref","unstructured":"Tamarat R, Silvestre JS, Durie M and Levy BI (2002) Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest82, 747\u2013756.","DOI":"10.1097\/01.LAB.0000017372.76297.EB"},{"key":"key\n\t\t\t\t20171010140911_R42","doi-asserted-by":"crossref","unstructured":"Tokuyama O, Nakamura Y, Muso A, Fujino Y, Ishiko O and Ogita S (2002) Vascular endothelial growth factor concentrations in follicular fluid obtained from IVF-ET patients: a comparison of hMG, clomiphene citrate, and natural cycle. J Assist Reprod Genet19, 19\u201323.","DOI":"10.1023\/A:1014006605859"},{"key":"key\n\t\t\t\t20171010140911_R43","doi-asserted-by":"crossref","unstructured":"Trounson A, Anderiesz C and Jones G (2001) Maturation of human oocytes in vitro and their developmental competence. Reproduction121, 51\u201375.","DOI":"10.1530\/rep.0.1210051"},{"key":"key\n\t\t\t\t20171010140911_R44","doi-asserted-by":"crossref","unstructured":"Van Blerkom J (2000) Intrafollicular influences on human oocyte developmental competence: perifollicular vascularity, oocyte metabolism and mitochondrial function. Hum Reprod15(Suppl 2), 173\u2013188.","DOI":"10.1093\/humrep\/15.suppl_2.173"},{"key":"key\n\t\t\t\t20171010140911_R45","doi-asserted-by":"crossref","unstructured":"Van Blerkom J, Antczak M and Schrader R (1997) The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod12, 1047\u20131055.","DOI":"10.1093\/humrep\/12.5.1047"},{"key":"key\n\t\t\t\t20171010140911_R46","doi-asserted-by":"crossref","unstructured":"Veeck LL (1988) Oocyte assessment and biological performance. Ann N Y Acad Sci541, 256\u2013274.","DOI":"10.1111\/j.1749-6632.1988.tb22263.x"},{"key":"key\n\t\t\t\t20171010140911_R47","doi-asserted-by":"crossref","unstructured":"Vrta\u010dnik Bokal E and Meden Vrtovec H (1998) Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome. Hum Reprod13, 815\u2013821.","DOI":"10.1093\/humrep\/13.4.815"},{"key":"key\n\t\t\t\t20171010140911_R48","doi-asserted-by":"crossref","unstructured":"Vrta\u010dnik Bokal E, Meden Vrtovec H, Osredkar J and Verdenik I (2003) Follicular fluid renin concentration in patients with polycystic ovaries treated with gonadotrophin in an in vitro fertilisation programme. Clin Chem Lab Med41, 663\u2013667.","DOI":"10.1515\/CCLM.2003.100"},{"key":"key\n\t\t\t\t20171010140911_R49","doi-asserted-by":"crossref","unstructured":"Yoshimura Y (1997) The ovarian renin-angiotensin system in reproductive physiology. Front Neuroendocrinol13, 247\u2013291.","DOI":"10.1006\/frne.1997.0152"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/20\/6\/1562\/2244127\/deh789.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T06:31:24Z","timestamp":1548829884000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/20\/6\/1562\/748634\/Prolonged-HCG-action-affects-angiogenic-substances"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,1]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,6]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deh789","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,6]]},"published":{"date-parts":[[2005,6,1]]}}}